Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypochlorous acid versus polyhexamethylene biguanide for diabetic foot ulcers
2020-001365-36Phase 3Active
- Sponsor
- NU-sjukvården
- Start
- Sep 2020
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in diabetic foot ulcer (DFU) comparing Hypochlorous acid with Polyhexamethylene biguanide (2 arms). Primary endpoint: Time to healing of diabetic foot ulcer. Started Sep 2020; status: active.
02
Drugs
hypochlorous acidpolihexanide
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on 2020-001365-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001365-36.